Dr. Gregory Vlacich, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Studies Esophageal Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
9 drugs studied
Area of expertise
1Esophageal Cancer
Stage III
Stage I
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Gregory Vlacich, M.D., Ph.D. is currently running
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
Intense Radiation + Chemotherapy
for Esophageal Cancer
Rates of local disease control in patients with locally advanced esophageal cancer who are not candidates for surgical resection are suboptimal. Despite treatment with chemotherapy and radiation therapy approximately half of patients will develop recurrence of their cancer at the site of the original primary cancer. Salvage therapy options are largely ineffective and nearly all patients who develop local disease recurrence will succumb to their cancer. Recent clinical trials for lung cancer have demonstrated that local tumor control can be improved safely with accelerated hypofractionated radiation therapy regimens in order to achieve radiation dose intensification. This clinical trial aims to adapt those techniques and assess the safety of such a regimen for the treatment of inoperable thoracic esophageal cancers.
Recruiting1 award Phase 1
More about Gregory Vlacich, M.D., Ph.D.
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gregory Vlacich, M.D., Ph.D. has experience with
- Paclitaxel
- Durvalumab
- Carboplatin AUC
- Radiation Therapy
- ViewRay MR-Linear Accelerator
- Carboplatin
Breakdown of trials Gregory Vlacich, M.D., Ph.D. has run
Esophageal Cancer
Non-Small Cell Lung Cancer
Adenocarcinoma
Esophageal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Vlacich, M.D., Ph.D. specialize in?
Gregory Vlacich, M.D., Ph.D. focuses on Esophageal Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Esophageal Cancer has involved Stage III patients, or patients who are Stage I.
Is Gregory Vlacich, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Gregory Vlacich, M.D., Ph.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Gregory Vlacich, M.D., Ph.D. has studied deeply?
Yes, Gregory Vlacich, M.D., Ph.D. has studied treatments such as Paclitaxel, Durvalumab, Carboplatin AUC.
What is the best way to schedule an appointment with Gregory Vlacich, M.D., Ph.D.?
Apply for one of the trials that Gregory Vlacich, M.D., Ph.D. is conducting.
What is the office address of Gregory Vlacich, M.D., Ph.D.?
The office of Gregory Vlacich, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.